Page last updated: 2024-11-05

thioridazine-5-sulfoxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thioridazine-5-sulfoxide: metabolite of thioridazine; cardiotoxic; RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID24494
CHEMBL ID3544852
MeSH IDM0122148

Synonyms (21)

Synonym
10h-phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylthio)-, 5-oxide
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine 5-oxide
thioridazine 5-oxide
thioridazine sulfoxide
yi69b9mw63 ,
unii-yi69b9mw63
7776-05-8
thioridazine-5-oxide
thioridazine-5-sulfoxide
FT-0675191
thioridazine 5-sulfoxide
thioridazine hydrochloride impurity c [ep impurity]
thioridazine sulphoxide
10-(2-(1-methylpiperidin-2-yl)ethyl)-2-methylsulfanylphenothiazine 5-oxide
thioridazine impurity c [ep impurity]
CHEMBL3544852
10-[2-[(2rs)-1-methylpiperidin-2-yl]ethyl]-2-(methylsulfanyl)-10h-phenothiazine 5-oxide (thioridazine 5-sulfoxide)
Q27294535
DTXSID80998951
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-5lambda~4~-phenothiazin-5(10h)-one
thioridazine 5-sulfoxide(mixture of diastereomers)

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Thioridazine-5-sulphoxide, N-desmethylthioridazine-5-sulphoxide and thioridazine-N-oxide diastereoisomers were found to be thioridazine metabolites following dosing in rats or after in-vitro incubation with rat liver homogenate."( Chromatographic separation of thioridazine sulphoxide and N-oxide diastereoisomers: identification as metabolites in the rat.
Buckley, DG; Curry, SH; Watkins, GM; Whelpton, R, 1986
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (55.56)18.7374
1990's2 (22.22)18.2507
2000's2 (22.22)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.52 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.23 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.69%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]